Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Marcus

Showing results (1-10 of 93) with videos related to

Pageof 10
Sort By:
The Dental Register|March 11, 2021
Experiments with NirvaninRobert Marcus
Best Practice & Research. Clinical Obstetrics & Gynaecology|July 9, 2002
Post-menopausal osteoporosisRobert Marcus
Seminars in Oncology|March 24, 2005
Use of 90Y-ibritumomab tiuxetan in non-Hodgkin's lymphomaRobert Marcus
Leukemia & Lymphoma|November 9, 2007
Pathogenesis of MALT lymphoma: implications for risk stratification and therapyRobert Marcus
Leukemia & Lymphoma|December 11, 2007
Distinguishing between entities--rationally based advances in the therapy of follicular lymphomaRobert Marcus
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|November 5, 2002
The role of estrogens and related compounds in the management of primary hyperparathyroidismRobert Marcus
BMJ (Clinical Research Ed.)|April 21, 2007
Should you tell patients about beneficial treatments that they cannot have? YesRobert Marcus
Leukemia & Lymphoma|May 25, 2004
Current treatment options in aggressive lymphomaRobert Marcus
European Journal of Haematology. Supplementum|January 9, 2007
The therapeutic use of rituximab in non-Hodgkin's lymphomaRobert Marcus, Anton Hagenbeek
Blood Reviews|June 24, 2003
Monoclonal antibody therapy for lymphomaPeter Campbell, Robert Marcus
Pageof 10

Showing results (1-10 of 93) with videos related to

Sort By:
Pageof 10
The Dental Register|March 11, 2021
Experiments with NirvaninRobert Marcus
Best Practice & Research. Clinical Obstetrics & Gynaecology|July 9, 2002
Post-menopausal osteoporosisRobert Marcus
Seminars in Oncology|March 24, 2005
Use of 90Y-ibritumomab tiuxetan in non-Hodgkin's lymphomaRobert Marcus
Leukemia & Lymphoma|November 9, 2007
Pathogenesis of MALT lymphoma: implications for risk stratification and therapyRobert Marcus
Leukemia & Lymphoma|December 11, 2007
Distinguishing between entities--rationally based advances in the therapy of follicular lymphomaRobert Marcus
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|November 5, 2002
The role of estrogens and related compounds in the management of primary hyperparathyroidismRobert Marcus
BMJ (Clinical Research Ed.)|April 21, 2007
Should you tell patients about beneficial treatments that they cannot have? YesRobert Marcus
Leukemia & Lymphoma|May 25, 2004
Current treatment options in aggressive lymphomaRobert Marcus
European Journal of Haematology. Supplementum|January 9, 2007
The therapeutic use of rituximab in non-Hodgkin's lymphomaRobert Marcus, Anton Hagenbeek
Blood Reviews|June 24, 2003
Monoclonal antibody therapy for lymphomaPeter Campbell, Robert Marcus
Pageof 10